Adipose tissue and related gynecological cancers George Valsamakis
|
|
- Solomon Richard
- 6 years ago
- Views:
Transcription
1 Adipose tissue and related gynecological cancers George Valsamakis Εndocrinologist Visiting Associate clinical Professor Warwick Medical School, UK European Scope Fellow in Obesity (IASO)
2
3 Obesity and adipocyte changes Obesity is characterized by: 1. an increase in adipocyte size and number, 2. changes in the levels of adipocytokine secretion, 3. recruitment of macrophages that release proinflammatory cytokines.
4 Cytokines production sources Adipocytes (mature fat cells) Fibroblats (stromal cells, preadipocytes) Macrophages (infiltrate adipose tissue)
5 Adipose tissue cells in Obesity
6 Adipocytokine mode of actions Endocrine Paracrine Autocrine
7 Adipokines as endocrine, paracrine, and autocrine factors in breast cancer risk and progression By L Vona Davis & DPRose Endocrine Related Cancer 2007
8 Η Δράση των λιποκυττοκινών
9 Λιπώδης ιστός και γυναικείο αναπαραγωγικό σύστημα
10
11 Summary of Mortality from Cancer According to Body-Mass Index for U.S. Women in the Cancer Prevention Study II, 1982 through Calle EE et al. N Engl J Med 2003;348:
12 Tumour development Effects of metabolic surgery and cancer
13 Obesity and mortality from cancer (Calle EE et al. NEJM 2003) Prospective study of 900,000 adults (495,477 women) free of cancer at the enrollment period. 57,145 deaths from cancer during the 16 yr follow up. For men the relative risk of death was 1.52 and for women 1.62( ). In women significant trends of increasing risk with higher BMI values were observed for death from cancer of the breast, uterus, cervix and ovary
14 Type of Cancer breast No of deaths Death rate RR (95%CI) BMI BMI BMI BMI BMI> ( ) 1.63 ( ) 1.7 ( ) 2.12 ( ) P for trend <0.001
15 Type of Cancer BMI BMI BMI BMI>40 Corpus and uterus No of deaths Death rate RR (95%CI) ( ) 2.53 ( ) 6.25 ( )
16 Type of Cancer BMI BMI BMI BMI>40 P for trend cervical No of deaths Death rate RR (95%CI) ( ) 1.23 ( ) 3.20 ( ) 0.001
17 Diabetes and lipids: association with breast cancer Attner B Cancer Causes Control, 2012 how the incidence of cancer is related to diabetes, obesity or abnormal blood lipids. Diagnosis of diabetes, obesity or abnormal blood lipids was studied 0-10 years prior to the diagnosis of cancer in 19,756 cases of cancer and in 147,324 controls matched regarding age, sex. Diabetes was significantly more common prior to cancer diagnosis in patients with liver, pancreatic, colon and urinary tract/bladder cancer Diabetes more common in breast cancer patients diagnosed with diabetes 0-4 years prior to the cancer diagnosis.
18 Diabetes and lipids: association with breast cancer (2) Attner B Cancer Causes Control, 2012 Obesity was significantly more common in patients with endometrial, colon and kidney cancer and with breast cancer above the age of 60 years in those where obesity was diagnosed close to the diagnosis of cancer. High blood lipids were significantly more common in patients with ovarian cancer and less common in patients with breast cancer
19 Obesity and estrogen related cancer Premenopause: estrogens act in an endocrine manner maintaining tumor growth in ER-positive breast cancers Postmenopause: aromatization of Δ4 in adipose tissue is the source of estrone and estradiol
20 Paracrine action and cancer adipose tissue fibroblasts surrounding the cancerous lesion 1.aromatase activity enhancing local estrogen synthesis 2.steroid diffuses from its origin site to interact to ER in the nearby tumor cells
21 R Kaacs et al. (Endocrine Related Cancer 2010) Relative risk of breast cancer among postmenopausal women by quintiles of serum steroid concentrations
22
23 Leptin-mechanisms Product of the ob gene Synthesized by adipocytes and preadipocytes Correlates positively with BMI Leptin levels higher in late follicular and luteal phase of the normal cycle Responsible for regulation of energy balance through effects at hypothalamus Conflicting results regarding serum levels and breast cancer risk (3 positive case-control studies vs 6 negative)
24 Paracrine actions Leptin on normal placental function during wound healing: produced by sc adipocytes for angiogenesis during repair process Local production in the anterior pituitary where it modulates thyrotropin secretion Paracrine activity in breast cancer cells when produced by surrounding breast fat cells
25 Autocrine action of leptin in breast cancer Presence of Leptin mrna and its corresponding protein in both ER positive and ER negative human breast cancer cell lines (O Brien et al 1999) Leptin receptors detected in the malignant epithelial cells of 83% of 76 invasive ductal breast carcinomas Activity at the tumor site to enhance the metastatic capacity of breast cancer cells (Ishikawa 2004, Garofalo 2006)
26 Leptin and cancerogenesis potential mechanisms Mitogen for various cell types (myelocytic, breast epithelial cells, vascular endothelial cells) Expression of leptin was found in normal mammary tissue, breast cancer tissue as well as in breast cancer cell lines Leptin-induced proliferation of breast cancer cell lines, increase of the expression of proteolytic enzymes that are essential in metastatic process stimulatory effect on angiogenesis Enhances aromatase activity. growth effect on estrogen receptor-positive human breast cancer cell lines through activation of MAP kinase protein pathway, of STAT 1,2,3 factors
27 Leptin and cancerogenesis: the evidence Activates ER in MCF-7 breast cancer cells without the involvement of estradiol (Catalano et al 2004) Interferes with the antiestrogenic action of pharmacological agents and stops the suppression of tumor proliferation (Garofalo 2004)
28 Επίπεδα λεπτίνης πλάσματος και καρκίνος μαστού: οι μελέτες
29 Breast Cancer Studies with leptin Mantzoros et al. (1999) found no difference between premenopausal patients with carcinoma in situ and healthy controls. An Italian case control study observed elevated plasma leptin levels in breast cancer patients and increase in adipose tissue leptin mrna levels (Tessitore et al. 2000, 2004). A study of invasive breast cancer from Greece reported significantly lower serum leptin levels in premenopausal breast cancer patients (Petridou et al. 2000).
30 Breast Cancer Studies with leptin (2) Miyoshi et al. (2006) no association between serum leptin levels and breast cancer risk correlation between serum leptin levels and intratumoral leptin mrna.(case control study)
31 Breast Cancer Studies with leptin (3) Chen et al. 100 controls & 100 newly diagnosed pre and post menopausal breast cancer patients serum leptin levels were not correlated to menopausal status signifnicantly higher in breast cancer group even at the absence of obesity
32 Εκφραση λεπτίνης και του υποδοχέα της στον καρκίνο του μαστού-αυτοκρινής δράση (οι μελέτες)
33 Leptin expression in breast cancer Enhanced Expression of Leptin and Leptin Receptor (OB-R) in Human Breast Cancer M Ishikawa et al. (Clinical Cancer Research 2004) 1. Leptin may have a promoting effect on the carcinogenesis and metastasis of breast cancer, possibly in an autocrine manner. 2. the expression of leptin and OB-R in breast cancer was significantly correlated (P < 0.01).
34 Leptin expression in breast cancer (2) Increased Expression of Leptin and the Leptin Receptor as a Marker of Breast Cancer Progression: Possible Role of Obesity- Related Stimuli C Garofalo et al. (Clinical Cancer Research 2006) 1. Leptin and ObR were significantly over-expressed in primary and metastatic breast cancer relative to non cancer tissues. 2. In primary tumors, leptin positively correlated with ObR, and both biomarkers were most abundant in G3 tumors. 3. Conclusion Leptin and ObR are ove-rexpressed in breast cancer, possibly due to hypoxia and/or overexposure of cells to insulin, IGF- I, and/or estradiol
35 Insulin and IGF-1 in breast cancer Insulin directly stimulates proliferation of breast cancer cell lines and lowers the levels of SHBG thus increasing the free estradiol availability. Some authors also found relationship between elevated IGF-1 levels and the risk of breast cancer development in premenopausal women.
36 Bidirectional Crosstalk between Leptin and Insulin-like Growth Factor-I Signaling Promotes Invasion and Migration of Breast Cancer Cells via Transactivation of Epidermal Growth Factor Receptor by N.K. Saxena et al. Cancer Research 2008 Co-treatment with leptin and IGF-I increases proliferation as well as migration and invasion of breast cancer cells.
37 Adiponectin action (1) Negative relation with BMI, synthesized by mature adipocytes Present in serum as trimer, hexamer and high molecular weight isoform Protects from insulin resistance, inflammation and modulates endothelial function 2 receptors: AdipoR1 in skeletal muscle and adipose tissue and AdipoR2 in liver. Through AdipoR1 exerts effects by autocrine and paracrine mechanism (Rasmussen 2006, Kang 2005)
38 Adiponectin effects in breast cancer biology Increased breast cancer risk with hypoadiponectinaemia Antimitogenic effect in breast cancer cell growth Enhances tumor cell apoptosis Inhibits tumor angiogenesis
39 Adiponectin actions (2) Inverse association of plasma levels and breast cancer risk (Miyoshi 2003, Mantzoros 2004, Chen 2006) Suppressive effects on breast cancer cell growth in vitro The presence of receptors for the ligand protein both endocrine and paracrine mode actions at the cell level.
40 Adiponectin actions (3) Low levels are considered a marker of aggressive phenotype No relationship with ER status or to tumor grade or stage
41 Low Adiponectin levels and breast cancer risk Mantzoros et al. (2004) found 1. an inverse relationship of circulating adiponectin levels and breast cancer risk in postmenopausal women independently of possible effects of IGF-1, leptin, BMI and other parameters. 2. No such association was found in premenopausal women.
42 Low Adiponectin levels and breast cancer risk (2) Miyoshi et al. (2003) described 1. an association of low serum adiponectin levels with increased risk of breast cancer 2. in both postmenopausal and premenopausal women
43 Plasma Adiponectin Concentrations and Risk of Incident Breast Cancer Shelley S. Tworoger JCEM 2007 Low risk for premenopausal women. Among postmenopausal women, adiponectin appeared more strongly inversely associated in women who never used PMH and women with low circulating estradiol levels Conclusion: Our results suggest that adiponectin may be inversely associated with postmenopausal breast cancer risk, particularly in a low-estrogen environment.
44 Απώλεια βάρους και καρκίνος μαστού
45 Figure. Relative Risk of Postmenopausal Breast Cancer Among Women Who Have Never Used Postmenopausal Hormones According to Weight Change Since Menopause. Eliassen, A. H. et al. JAMA 2006 Copyright restrictions may apply.
46 Unadjusted Cumulative Mortality. Sjöström L et al. N Engl J Med 2007.
47 Καρκίνος Ενδομητρίου
48 Obesity and endometrial cancer epidemiology (Bergstrom A.et al. Int. J. Cancer, 91: , 2001,) (Tornberg S. A. et al. Br. J. Cancer, 69: , 1994) Endometrial cancer incidence of 24 in 100,000 Accounts ~40% of endometrial cancer in affluent states more common in menopausal women Women who are obese are two to four times more likely to develop endometrial cancer in both pre and post menopause Οbese women who experience early menopause seem to be at an even greater risk.
49 How Obesity Increases endometrial Cancer Risk 1. Unknown mechanism 2. how much cancer risk increases with rising BMI can vary across ethnicities: ie:, Japanese-American women increase their endometrial cancer risk with only a small BMI increase, Caucasian and African-American women who increase their risk only with larger BMI increases.
50 Obesity endocrine effects-mechanisms Schmandt RE Am J Obstet Gynecol unopposed estrogen is a risk for hyperplasia and endometrial cancer. diabetes and hypertension are also often considered risk factors for this type of cancer, obesity seems to be the common link. Adipocytes express aromatase that converts ovarian androgens into estrogens, which induce endometrial proliferation. Lower Sex hormone-binding globulin levels, the level of unbound biologically active hormone is higher. The level of insulin-binding globulins is reduced and free insulin levels are elevated. Insulin and insulin-like growth factors (IGF) also exert a proliferative effect on the endometrium, through pathways that are already hyperactive in women at risk for endometrial cancer
51 Endogenous hormones and endometrial cancer development. Kaaks R et al. Cancer Epidemiol Biomarkers Prev 2002;11: by American Association for Cancer Research
52 Endometrial cancer and leptin (1) Petridou et al. (2002) a positive association between high leptin levels and endometrial cancer
53 Endometrial cancer and leptin (2) (Kitawaki et al.2000) short and long forms of leptin receptor mrna and proteins, but not leptin itself, were expressed in the endometrium The expression peaked -mainly the long form of leptin receptor -in early secretory phase and declined during the mid- and late secretory phases towards menstruation..
54 Endometrial cancer and leptin (3) Yuan et al. (2004) : 1. described elevated leptin levels in endometrial cancer patients. 2. The elevated leptin levels in endometrial carcinogenesis may reflect rather the obesity itself than the direct role of leptin in endometrial cancer development. 3. Lower expression of short leptin receptor isoform was observed in most endometrial cancers, especially in the poorly differentiated ones
55 Adiponectin and endometrial Petridou et al. (2003) cancer 1. showed an inverse significant association of endometrial cancer in women younger than 65 years of age. 2. Obesity and adiponectin had independent roles in promoting endometrial cancer. The results were confirmed in another study published by Dal Maso et al. (2004).
56 Adipocytokines and endometrial cancer Dallal CL et al. Endocrin Relat Cancer case-control study, (n=15,595), pre-diagnostic serum leptin, total adiponectin, and high-molecularweight (HMW) adiponectin in relation to endometrial cancer among postmenopausal women. During the 10-year follow-up, 62 incident endometrial cases were identified and matched to 124 controls on age, geographical site, time of fasting blood draw at baseline ( ), and trial participation status.
57 Adipocytokines and endometrial cancer (2) Dallal CL et al. Endocrin Relat Cancer 2013 Endometrial cancer risk was significantly associated with higher leptin levels, adjusted for E2 and C-peptide (OR=2.96; 95% CI, ; P trend <0.01). After further adjustment for BMI, the estimates were attenuated and the positive trend was no longer statistically significant (OR=2.11; 95% CI, ; P trend=0.18). No significant associations were observed with adiponectin or HMW adiponectin and endometrial cancer. Our findings with leptin suggest that the leptin-bmi axis might increase endometrial cancer risk through mechanisms other than estrogendriven proliferation
58 Association of Obesity with stage-grade of endometrial cancer Reeves KV Gynecol Oncol 2011 prospectively examined the effects of body mass index (BMI) and waist-tohip ratio (WHR) on incidence, stage, and grade of endometrial cancer. studied postmenopausal women enrolled in the Women's Health Initiative.. Follow up 7.8 years, 806 women were diagnosed with endometrial cancer. incidence was higher among Whites, stage and grade were similar between Whites and Blacks.
59 Association of Obesity with stage-grade of endometrial cancer Reeves KV Gynecol Oncol 2011 (2) Elevated BMI (HR 1.76, 95% confidence interval [CI] ) and WHR (HR 1.33, 95% CI ) increased endometrial cancer risk. No associations were observed between BMI or WHR and disease stage or grade.
60 Association of Obesity with stage-grade of endometrial cancer (2) Lino Silva LS et al. Clin Transl Oncol 2013 Investigated BMI relation to clinical-pathological characteristics in primary tumor and disease outcome in endometrial cancer. 147 women primarily treated for endometrial carcinoma High BMI was related to endometrioid histology and low/intermediate grade In survival analysis adjusting for age, histological subtype and grade, BMI showed no independent prognostic impact. High BMI was significantly associated with markers of non-aggressive disease
61 Association between obesity and mortality in endometrial cancer Arem H et al. International Journal of Obesity (2012) performed a medline search,12 studies met inclusion criteria. Four of the included studies reported a statistically or marginally significant association between obesity and higher all cause mortality among endometrial cancer survivors after multivariate adjustment. Of the five studies that examined progression-free survival and the two studies reporting on disease-specific mortality, none reported an association with obesity.
62 Weight loss and cancer risk reduction: metformin effect Schmandt RE et al. Am J Obstet Gynecol Weight loss by diet, exercise, or bariatric surgery are all associated with this protective effect. Treatment with metformin is associated with: 1. a reduction in insulin level 2. weight loss 3. activates pathways that inhibit cell proliferation. 4. reduces adipocyte aromatase activity 5. increases progesterone receptor expression.
63
64 Ευχαριστω
Crosstalk between Adiponectin and IGF-IR in breast cancer. Prof. Young Jin Suh Department of Surgery The Catholic University of Korea
Crosstalk between Adiponectin and IGF-IR in breast cancer Prof. Young Jin Suh Department of Surgery The Catholic University of Korea Obesity Chronic, multifactorial disorder Hypertrophy and hyperplasia
More informationDiabetes Mellitus and Breast Cancer
Masur K, Thévenod F, Zänker KS (eds): Diabetes and Cancer. Epidemiological Evidence and Molecular Links. Front Diabetes. Basel, Karger, 2008, vol 19, pp 97 113 Diabetes Mellitus and Breast Cancer Ido Wolf
More informationTargeting Inflammation in Breast Cancer Pathogenesis
Targeting Inflammation in Breast Cancer Pathogenesis Clifford Hudis, M.D. Chief, Breast Cancer Medicine Service Attending Physician, MSKCC Professor of Medicine, Weill Cornell Medical College August 7,
More informationAdipokines as endocrine, paracrine, and autocrine factors in breast cancer risk and progression
REVIEW Endocrine-Related Cancer (2007) 14 189 206 Adipokines as endocrine, paracrine, and autocrine factors in breast cancer risk and progression Linda Vona-Davis and David P Rose Department of Surgery
More informationWEIGHT GAIN DURING MENOPAUSE EMERGING RESEARCH
MENOPAUSE WHEN DOES IT OCCUR? The cessation of the menstrual cycle for one year. WEIGHT GAIN DURING MENOPAUSE EMERGING RESEARCH Jan Schroeder, Ph.D. Chair of The Department of Kinesiology California State
More informationLifestyle Factors and Cancer Survivorship: Observational Findings of Weight, Physical Activity, and Diet on Survival
Lifestyle Factors and Cancer Survivorship: Observational Findings of Weight, Physical Activity, and Diet on Survival Melinda L. Irwin, PhD, MPH Associate Professor of Epidemiology Yale School of Medicine
More informationChapter 2 The Link Between Obesity and Breast Cancer Risk: Epidemiological Evidence
Chapter 2 The Link Between Obesity and Breast Cancer Risk: Epidemiological Evidence 2.1 BMI and Breast Cancer Risk BMI is routinely used to qualify an individual s adiposity, yet it is simply a measure
More informationHormone. Free Androgen Index. 2-Hydroxyestrone. Reference Range. Hormone. Estrone Ratio. Free Androgen Index
Hormonal Health PATIENT: Sample Report TEST REF: TST-12345 Hormonal Health 0.61 0.30-1.13 ng/ml DHEA-S 91 35-430 mcg/dl tient: SAMPLE TIENT e: x: N: Sex Binding Globulin 80 18-114 nmol/l Testosterone 0.34
More informationSAMPLE REPORT. Order Number: PATIENT. Age: 40 Sex: F MRN:
Patient: Age: 40 Sex: F MRN: SAMPLE PATIENT Order Number: Completed: Received: Collected: SAMPLE REPORT Progesterone ng/ml 0.34 0.95 21.00 DHEA-S mcg/dl Testosterone ng/ml 48 35 0.10 0.54 0.80 430 Sex
More informationClaudin-4 Expression in Triple Negative Breast Cancer: Correlation with Androgen Receptors and Ki-67 Expression
Claudin-4 Expression in Triple Negative Breast Cancer: Correlation with Androgen Receptors and Ki-67 Expression Mona A. Abd-Elazeem, Marwa A. Abd- Elazeem Pathology department, Faculty of Medicine, Tanta
More informationPhysical Activity & Cancer What We Know, What We Don t Know. Anne McTiernan, MD, PhD Fred Hutchinson Cancer Research Center Seattle, WA
Physical Activity & Cancer What We Know, What We Don t Know Anne McTiernan, MD, PhD Fred Hutchinson Cancer Research Center Seattle, WA What We Know Extensive epidemiologic research on relationship between
More informationAdipose Tissue as an Endocrine Organ. Abdel Moniem Ibrahim, MD Professor of Physiology Cairo University
Adipose Tissue as an Endocrine Organ Abdel Moniem Ibrahim, MD Professor of Physiology Cairo University Functions of Adipose Tissue Adipose tissue expresses and secretes a variety of bioactive peptides,
More information1. During the follicular phase of the ovarian cycle, the hypothalamus releases GnRH.
1. During the follicular phase of the ovarian cycle, the hypothalamus releases GnRH. 2. This causes the anterior pituitary to secrete small quantities of FSH and LH. 3. At this time, the follicles in the
More information5. Summary of Data Reported and Evaluation
168 IARC MONOGRAPHS VOLUME 91 5. Summary of Data Reported and Evaluation 5.1 Exposure data The first oral hormonal contraceptives that were found to inhibit both ovulation and implantation were developed
More informationTherapeutic Cohort Results
Patient: SAMPLE PATIENT DOB: Sex: MRN: Menopause Plus - Salivary Profile Therapeutic Cohort Results Hormone Average Result QUINTILE DISTRIBUTION 1st 2nd 3rd 4th 5th Therapeutic Range* Estradiol (E2) 8.7
More informationType 2 Diabetes and Cancer: Is there a link?
Type 2 Diabetes and Cancer: Is there a link? Sonali Thosani, MD Assistant Professor Department of Endocrine Neoplasia & Hormonal Disorders MD Anderson Cancer Center No relevant financial disclosures Objectives
More informationMedical risk reducing strategies for breast cancer
Medical risk reducing strategies for breast cancer PROF. DR. H. DEPYPERE Menopause Clinic, University Hospital, Ghent, Belgium Life expectancy in Belgium 46,6 y in 1880 and 83,8 y in 2014 2 Women Men Aantal
More informationI. Endocrine System & Hormones Figure 1: Human Endocrine System
I. Endocrine System & Hormones Figure 1: Human Endocrine System Endocrine System: a) Endocrine glands are ductless since they lack specific vessels for the transport of hormones throughout the body. Instead,
More informationReproductive physiology
Reproductive physiology Sex hormones: Androgens Estrogens Gestagens Learning objectives 86 (also 90) Sex Genetic sex Gonadal sex Phenotypic sex XY - XX chromosomes testes - ovaries external features Tha
More informationTherapeutic Cohort Results
Patient: PAGE LOVE DOB: January 11, 1983 Sex: F MRN: 1232704193 Order Number: J9020008 Completed: July 08, 2016 Received: July 02, 2016 Collected: July 01, 2016 Aum Healing Center Sarika Arora MD 332 Newbury
More informationONLINE CONTINUING EDUCATION ACTIVITY
ONLINE CONTINUING EDUCATION ACTIVITY Take free quizzes online at acsjournals.com/ce ARTICLE TITLE: Obesity and Adverse Breast Cancer Risk and Outcome: Mechanistic Insights and Strategies for Intervention
More informationHormone Balance - Female Report SAMPLE. result graph based on Luteal Phase. result graph based on Luteal Phase
Patient Name: Patient DOB: Gender: Physician: Test Hormone Balance - Female Report SAMPLE Grote, Mary Jane Batch Number: B6437 2/16/1954 Accession Number: N52281 F Date Received: 2/3/2015 Any Lab Test
More information5 Mousa Al-Abbadi. Ola Al-juneidi & Obada Zalat. Ahmad Al-Tarefe
5 Mousa Al-Abbadi Ola Al-juneidi & Obada Zalat Ahmad Al-Tarefe Abnormal Uterine Bleeding (AUB) AUB is a very common scenario or symptom where women complain of menorrhagia (heavy and/or for long periods),
More informationDIABETES, PHYSICAL ACTIVITY AND ENDOMETRIAL CANCER. Emilie Friberg
Division of Nutritional Epidemiology, Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden, 2006 DIABETES, PHYSICAL ACTIVITY AND ENDOMETRIAL CANCER Emilie Friberg Stockholm 2006
More informationBreast Cancer. Dr. Andres Wiernik 2017
Breast Cancer Dr. Andres Wiernik 2017 Agenda: The Facts! (Epidemiology/Risk Factors) Biological Classification/Phenotypes of Breast Cancer Treatment approach Local Systemic Agenda: The Facts! (Epidemiology/Risk
More informationInvestigation: The Human Menstrual Cycle Research Question: How do hormones control the menstrual cycle?
Investigation: The Human Menstrual Cycle Research Question: How do hormones control the menstrual cycle? Introduction: The menstrual cycle (changes within the uterus) is an approximately 28-day cycle that
More informationBreast Cancer: Weight and Exercise. Anne McTiernan, MD, PhD. Fred Hutchinson Cancer Research Center Seattle, WA
Breast Cancer: Weight and Exercise Anne McTiernan, MD, PhD Fred Hutchinson Cancer Research Center Seattle, WA Associations of Obesity with Overall & Breast Cancer Specific Survival Survival Obese vs. Non-obese
More informationHormonal Control of Human Reproduction
Hormonal Control of Human Reproduction Bởi: OpenStaxCollege The human male and female reproductive cycles are controlled by the interaction of hormones from the hypothalamus and anterior pituitary with
More informationEstrogens and progestogens
Estrogens and progestogens Estradiol and Progesterone hormones produced by the gonads are necessary for: conception embryonic maturation development of primary and secondary sexual characteristics at puberty.
More informationReproductive System (Hormone Function) Physiology Department Medical School, University of Sumatera Utara
Reproductive System (Hormone Function) Physiology Department Medical School, University of Sumatera Utara 1 Endocrine Control: Three Levels of Integration Hormones of the hypothalamic-anterior pituitary
More informationSoyfood Consumption and Breast Cancer Survival. Xiao Ou Shu, M.D., Ph.D. Ingram Professor of Cancer Research Vanderbilt University, U.S.A.
Soyfood Consumption and Breast Cancer Survival Xiao Ou Shu, M.D., Ph.D. Ingram Professor of Cancer Research Vanderbilt University, U.S.A. Objectives Brief summary of the health benefits of soyfood consumption
More informationHSN301 Diet and Disease Entire Note Summary
Topic 1: Metabolic Syndrome Learning Objectives: 1. Define obesity 2. Factors causing obesity 3. Obesity as a risk factor for metabolic syndrome 4. The pathogenesis of metabolic syndrome 5. Treatment of
More informationPamela J. Goodwin, M.D., M.Sc., F.R.C.P.C.
Overview of the Evidence Relating Cancer Outcomes to Obesity and Body Weight Pamela J. Goodwin, M.D., M.Sc., F.R.C.P.C. Professor of Medicine University of Toronto Obesity Trends* Among U.S. Adults BRFSS,
More informationBIOL212 Biochemistry of Disease. Metabolic Disorders - Obesity
BIOL212 Biochemistry of Disease Metabolic Disorders - Obesity Obesity Approx. 23% of adults are obese in the U.K. The number of obese children has tripled in 20 years. 10% of six year olds are obese, rising
More informationEffect of Obesity-associated Iron dysregulation on Breast Cancer Risk in Postmenopausal Women
Effect of Obesity-associated Iron dysregulation on Breast Cancer Risk in Postmenopausal Women BY PUJA AGARWAL BS, University of Delhi, India 2001 MS, University of Delhi, India 2003 THESIS Submitted as
More informationCASE 41. What is the pathophysiologic cause of her amenorrhea? Which cells in the ovary secrete estrogen?
CASE 41 A 19-year-old woman presents to her gynecologist with complaints of not having had a period for 6 months. She reports having normal periods since menarche at age 12. She denies sexual activity,
More informationHEALTH CARE DISPARITIES. Bhuvana Ramaswamy MD MRCP The Ohio State University Comprehensive Cancer Center
HEALTH CARE DISPARITIES Bhuvana Ramaswamy MD MRCP The Ohio State University Comprehensive Cancer Center Goals Understand the epidemiology of breast cancer Understand the broad management of breast cancer
More informationSoyfood Consumption and Breast Cancer Survival. Xiao Ou Shu, M.D., Ph.D. Ingram Professor of Cancer Research Vanderbilt University, U.S.A.
Soyfood Consumption and Breast Cancer Survival Xiao Ou Shu, M.D., Ph.D. Ingram Professor of Cancer Research Vanderbilt University, U.S.A. Objectives Brief summary of the health benefits of soyfood consumption
More informationHost Factors that Increase Breast Cancer Risk
Host Factors that Increase Breast Cancer Risk 30 th Annual Miami Breast Cancer Conference March 7-10, 2013 Debu Tripathy, MD Professor of Medicine University of Southern California Norris Comprehensive
More informationAdrenal Stress Profile (Saliva)
Adrenal Stress Profile (Saliva) Ireland Cortisol Levels Sample 1 Post Awakening Sample 2 (+ 4-5 Hours) Sample 3 (+ 4-5 Hours) Sample 4 (Prior to Sleep) 11.42 2.10 1.60 0.47 Sum of Cortisol 15.590 DHEA
More informationThe reproductive lifespan
The reproductive lifespan Reproductive potential Ovarian cycles Pregnancy Lactation Male Female Puberty Menopause Age Menstruation is an external indicator of ovarian events controlled by the hypothalamicpituitary
More informationOne Day Hormone Check
One Day Hormone Check DOB: Sex: F MRN: Order Number: Completed: Received: Collected: Salivary Hormone Results Estradiol pmol/l >3330.0 Testosterone pmol/l
More informationEndocrinology of the Female Reproductive Axis
Endocrinology of the Female Reproductive Axis girlontheriver.com Geralyn Lambert-Messerlian, PhD, FACB Professor Women and Infants Hospital Alpert Medical School at Brown University Women & Infants BROWN
More informationTherapeutic Cohort Results
Patient: JANE DOE DOB: December 31, 1968 Sex: F MRN: Order Number: Completed: February 26, 2016 Received: February 26, 2016 Collected: February 26, 2016 One Day Hormone Check - Salivary Profile Therapeutic
More informationDiet, obesity, lifestyle and cancer prevention:
Diet, obesity, lifestyle and cancer prevention: Epidemiologic perspectives Graham A Colditz, MD DrPH Niess-Gain Professor Chief, November, 2017 Outline Review evidence on contribution of diet, obesity,
More informationReproductive physiology. About this Chapter. Case introduction. The brain directs reproduction 2010/6/29. The Male Reproductive System
Section Ⅻ Reproductive physiology Ming-jie Wang E-Mail: mjwang@shmu.edu.cn About this Chapter The reproductive organs and how they work the major endocrine functions of sexual glands actions of sex hormones
More informationΦΛΕΓΜΟΝΗ ΚΑΙ ΔΙΑΒΗΤΗΣ
ΦΛΕΓΜΟΝΗ ΚΑΙ ΔΙΑΒΗΤΗΣ ΘΩΜΑΣ ΠΑΠΑΔΟΠΟΥΛΟΣ, MD, PHD ΕΠΕΜΒΑΤΙΚΟΣ ΚΑΡΔΙΟΛΟΓΟΣ ΙΑΤΡΙΚΟ ΔΙΑΒΑΛΚΑΝΙΚΟ ΚΕΝΤΡΟ Inflammation as a cause of disease has entered the popular imagination. Diet ( macronutrients )
More informationChapter 27 The Reproductive System. MDufilho
Chapter 27 The Reproductive System 1 Figure 27.19 Events of oogenesis. Before birth Meiotic events 2n Oogonium (stem cell) Mitosis Follicle development in ovary Follicle cells Oocyte 2n Primary oocyte
More informationAchieving Pregnancy: Obesity and Infertility. Jordan Vaughan, MSN, APN, WHNP-BC Women s Health Nurse Practitioner Nashville Fertility Center
Achieving Pregnancy: Obesity and Infertility Jordan Vaughan, MSN, APN, WHNP-BC Women s Health Nurse Practitioner Nashville Fertility Center Disclosures Speakers Bureau EMD Serono Board of Directors Nurse
More information5. Summary of Data Reported and Evaluation
326 5. Summary of Data Reported and Evaluation 5.1 Exposure data Combined estrogen progestogen menopausal therapy involves the co-administration of an estrogen and a progestogen to peri- or postmenopausal
More informationNatural Hormones Replacement An Evidence and Practice Based Approach
Natural Hormones Replacement An Evidence and Practice Based Approach Andres Ruiz, PharmD, MSc, FACA President/Partner Stonegate Pharmacy PRESENTED BY THE AMERICAN COLLEGE OF APOTHECARIES 2830 SUMMER OAKS
More informationEndocrine system. Coordination & regulation Glands Hormones
Endocrine system Coordination & regulation Glands Hormones Endocrine system structures Anatomy - Dispersed system of glands that communicate with each other & all body cells via hormones. Endocrine glands:
More informationPhysiology of Male Reproductive System
Physiology of Male Reproductive System the anterior pituitary gland serves as the primary control of reproductive function at puberty Ant Pituitary secretes FSH & large amounts of LH (ICSH) FSH & LH cause
More informationHormones and the Endocrine System Chapter 45. Intercellular communication. Paracrine and Autocrine Signaling. Signaling by local regulators 11/26/2017
Hormones and the Endocrine System Chapter 45 Intercellular communication Endocrine signaling Local regulators Paracrine and autocrine signaling Neuron signaling Synaptic and neuroendocrine signaling Paracrine
More informationPERIMENOPAUSE. Objectives. Disclosure. The Perimenopause Perimenopause Menopause. Definitions of Menopausal Transition: STRAW.
PERIMENOPAUSE Patricia J. Sulak, MD Founder, Living WELL Aware LLC Author, Should I Fire My Doctor? Author, Living WELL Aware: Eleven Essential Elements to Health and Happiness Endowed Professor Texas
More informationMULTIPLE CHOICE: match the term(s) or description with the appropriate letter of the structure.
Chapter 27 Exam Due NLT Thursday, July 31, 2015 Name MULTIPLE CHOICE: match the term(s) or description with the appropriate letter of the structure. Figure 27.1 Using Figure 27.1, match the following:
More informationModule J ENDOCRINE SYSTEM. Learning Outcome
Module J ENDOCRINE SYSTEM Topic from HAPS Guidelines General functions of the endocrine system Chemical classification of hormones & mechanism of hormone actions at receptors. Control of hormone secretion
More informationEndocrine system. Coordination & regulation Glands Hormones
Endocrine system Coordination & regulation Glands Hormones Endocrine system structures Anatomy - Dispersed system of glands that communicate with each other & all body cells via hormones. Endocrine glands:
More informationMetabolic Syndrome and HCC. Jacob George
Metabolic Syndrome and HCC Jacob George MetS and risk of HCC and ICC All with HCC and ICC between 1993 and 2005 identified in the Surveillance, Epidemiology, and End Results (SEER)-Medicare database. For
More informationHormones of brain-testicular axis
(Hormone Function) Hormones of brain-testicular axis anterior pituitary drives changes during puberty controlled by GnRH from hypothalamus begins to secrete FSH, LH LH targets interstitial endocrinocytes
More informationDisclosures. Learning Objectives. Effects of Hormone Therapy on the Metabolic Syndrome and Cardiovascular Disease. None
Effects of Hormone Therapy on the Metabolic Syndrome and Cardiovascular Disease Micol S. Rothman, MD Associate Professor of Medicine Endocrinology, Diabetes and Metabolism Clinical Director Metabolic Bone
More informationGynecologic Cancers are many diseases. Gynecologic Cancers in the Age of Precision Medicine Advances in Internal Medicine. Speaker Disclosure:
Gynecologic Cancer Care in the Age of Precision Medicine Gynecologic Cancers in the Age of Precision Medicine Advances in Internal Medicine Lee-may Chen, MD Department of Obstetrics, Gynecology & Reproductive
More information1st Year MB/BDS Plenary Lecture What is a Hormone?
1st Year MB/BDS Plenary Lecture What is a Hormone? The term hormone (from the Greek for I arouse to activity or I excite) was first used by Starling in 1905. Hormones are just one type of first (or primary)
More informationPolycystic Ovary Syndrome
Polycystic Ovary Syndrome Definition: the diagnostic criteria Evidence of hyperandrogenism, biochemical &/or clinical (hirsutism, acne & male pattern baldness). Ovulatory dysfunction; amenorrhoea; oligomenorrhoea
More information5. SUMMARY OF DATA. 5.1 Exposure data
5. SUMMARY OF DATA 5.1 Exposure data Obesity is the accumulation of excess body fat. Body mass index (BMI) is commonly used as a proxy measure of body fatness, because it correlates strongly with both
More informationOne Day Hormone Check
One Day Hormone Check Patient: EMILY TEST DOB: January 18, 1948 Sex: F MRN: 0000000004 Order Number: J5070009 Completed: March 07, 2014 Received: March 07, 2014 Collected: March 07, 2014 Alec Smart, ND
More informationIncreased Risk of Breast Cancer: Screening and Prevention. Elizabeth Pritchard, MD 4/5/2017
Increased Risk of Breast Cancer: Screening and Prevention Elizabeth Pritchard, MD 4/5/2017 No disclosures Defining Risk Risk Factors Modifiable Lifestyle obesity physical activity alcohol consumption breast
More informationSerum levels of 25-OH vitamin D, folic acid and testosterone in patients with breast cancer: a case control study
Asian Biomedicine Vol. 5 No. 5 October 2011; 663-667 Brief communication (Original) DOI: 10.5372/1905-7415.0505.097 Serum levels of 25-OH vitamin D, folic acid and testosterone in patients with breast
More informationBreast Cancer: Weight and Exercise. Anne McTiernan, MD, PhD. Fred Hutchinson Cancer Research Center Seattle, WA
Breast Cancer: Weight and Exercise Anne McTiernan, MD, PhD Fred Hutchinson Cancer Research Center Seattle, WA Associations of Obesity with Overall & Breast Cancer Specific Survival Survival Obese vs. Non-obese
More informationTRHC.UEMEE Ph P y h si s o i logy l of fmen M str st u r at a i t on i
. TRHCUEMEE Physiology of Menstruation Learning objectives: By the end of this lecture the students should be able to: Define menstruation. List the Characters of normal menstruation Enumerate Components
More informationSumida T, Hamakawa H. Telomerase and oral cancer. Oral Oncol. 37(4): ,
Sogawa K, Yamada T, Sumida T, Hamakawa H, Oda H, Tashiro S, Matsuda M, Matsumoto K, Okutani K Induction of K-562 cell apoptosis and inhibitory effect of DNA topoisomerase-i by a marine microalgae G3 polysaccharide.
More informationMETABOLIC SYNDROME IN REPRODUCTIVE FEMALES
METABOLIC SYNDROME IN REPRODUCTIVE FEMALES John J. Orris, D.O., M.B.A Division Head, Reproductive Endocrinology & Infertility, Main Line Health System Associate Professor, Drexel University College of
More informationElisa V. Bandera, MD, PhD
Elisa V. Bandera, MD, PhD Associate Professor of Epidemiology Rutgers Cancer Institute of New Jersey Rutgers School of Public Health American Institute for Cancer Research Annual Conference on Food, Nutrition,
More informationPolycystic Ovarian Syndrome (PCOS) LOGO
Polycystic Ovarian Syndrome (PCOS) Ma qianhong Ob/Gyn Department LOGO Contents Epidemiology and Definition Pathophysiology, Endocrinological Features Diagnostic Criteria Treatment Prognosis Introduction
More informationIMPACT OF NUTRITION ON GYNECOLOGICAL HEALTH OF FEMALE ADOLESCENTS
IMPACT OF NUTRITION ON GYNECOLOGICAL HEALTH OF FEMALE ADOLESCENTS Kedikova S. MD, PhD Medical University Sofia, Bulgaria University Hospital Maichin dom Sofia NUTRITION WHO - Nutrition is the intake of
More informationUterine Fibroids: No financial disclosures. Current Challenges, Promising Future. Off-label uses of drugs. Alison Jacoby, MD.
Uterine Fibroids: Current Challenges, Promising Future Alison Jacoby, MD Professor, Dept of Obstetrics, Gynecology and Reproductive Sciences No financial disclosures Off-label uses of drugs The BIG Questions
More informationContents 1 The Windows of Susceptibility to Breast Cancer 2 The So Called Pre-Neoplastic Lesions and Carcinoma In Situ
Contents 1 The Windows of Susceptibility to Breast Cancer... 1 1.1 Introduction... 1 1.2 Risk Factor and Etiological Agents... 2 1.3 The Concept of the Windows of Susceptibility to Carcinogenesis... 5
More informationSubject Index. hypothalamic-pituitary-adrenal axis 158. Atherosclerosis, ghrelin role AVP, see Arginine vasopressin.
Subject Index Acromegaly, somatostatin analog therapy dopamine agonist combination therapy 132 efficacy 132, 133 overview 130, 131 receptor subtype response 131, 132 SOM30 studies 131, 132 ACTH, see Adrenocorticotropic
More informationEndometrial line thickness in different conditions.
Endometrial line thickness in different conditions 1 Endometrial thickens in response to Rising estrogen levels during the menstrual cycle and then shedding endometrial at the times of menses 2 The thickens
More informationChapter 14 Reproduction Review Assignment
Date: Mark: _/45 Chapter 14 Reproduction Review Assignment Multiple Choice Identify the choice that best completes the statement or answers the question. 1. Use the diagram above to answer the next question.
More informationGynecologic Cancers are many diseases. Speaker Disclosure: Gynecologic Cancer Care in the Age of Precision Medicine. Controversies in Women s Health
Gynecologic Cancer Care in the Age of Precision Medicine Gynecologic Cancers in the Age of Precision Medicine Controversies in Women s Health Lee-may Chen, MD Department of Obstetrics, Gynecology & Reproductive
More informationMikhail G. Kolonin Editor. Adipose Tissue and Cancer
Mikhail G. Kolonin Editor Adipose Tissue and Cancer Adipose Tissue and Cancer Mikhail G. Kolonin Editor Adipose Tissue and Cancer Editor Mikhail G. Kolonin Institute of Molecular Medicine Center for Stem
More informationPolycystic Ovary Syndrome HEATHER BURKS, MD OU PHYSICIANS REPRODUCTIVE MEDICINE SEPTEMBER 21, 2018
Polycystic Ovary Syndrome HEATHER BURKS, MD OU PHYSICIANS REPRODUCTIVE MEDICINE SEPTEMBER 21, 2018 Learning Objectives At the conclusion of this lecture, learners should: 1) Know the various diagnostic
More informationBreast Cancer Prevention for the Population at Large
Breast Cancer Prevention for the Population at Large Jack Cuzick Centre for Cancer Prevention Wolfson Institute of Preventive Medicine St Bartholomew s Medical School Queen Mary University of London London,
More informationFemale Reproductive System. Lesson 10
Female Reproductive System Lesson 10 Learning Goals 1. What are the five hormones involved in the female reproductive system? 2. Understand the four phases of the menstrual cycle. Human Reproductive System
More informationStage 4 - Ovarian Cancer Symptoms
WELCOME Stage 4 - Ovarian Cancer Symptoms University of Baghdad College of Nursing Department of Basic Medical Sciences Overview of Anatomy and Physioloy II Second Year Students Asaad Ismail Ahmad,
More informationCynthia Morris DO, FACOOG, FACOS Medical Director, Women s Wellness Center Fayette County Memorial Hospital
Cynthia Morris DO, FACOOG, FACOS Medical Director, Women s Wellness Center Fayette County Memorial Hospital Touchdown to CME Eighth District Academy of Osteopathic Medicine & Surgery October 8. 2017 Goals
More informationHormones and cancer -risks and benefits
Hormones and cancer -risks and benefits Terhi Piltonen M.D., PhD., Associate Professor Consultant, Clinical Researcher for the Finnish Medical Foundation Department of Obstetrics and Gynecology PEDEGO
More informationINSULIN RESISTANCE, POLYCYSTIC OVARIAN SYNDROME An Overview
INSULIN RESISTANCE, POLYCYSTIC OVARIAN SYNDROME An Overview University of PNG School of Medicine & Health Sciences Division of Basic Medical Sciences PBL MBBS III VJ Temple 1 Insulin Resistance: What is
More informationResearching Genetic Influences in Different Racial/Ethnic Populations and Cancer
Researching Genetic Influences in Different Racial/Ethnic Populations and Cancer Lenora WM Loo, PhD Assistant Professor (Specialist) University of Hawaii Cancer Center Off-Label Use Disclosure I do not
More informationObesity and Risk of Breast Cancer
Obesity and Risk of Breast Cancer Ayca Gucalp, MD Assistant Attending Memorial Sloan Kettering Cancer Center Instructor of Medicine Weill Cornell Medical College September 5 th, 2014 Case 64 year old postmenopausal
More informationROLE OF HORMONAL ASSAY IN DIAGNOSING PCOD DR GAANA SREENIVAS (JSS,MYSURU)
ROLE OF HORMONAL ASSAY IN DIAGNOSING PCOD DR GAANA SREENIVAS (JSS,MYSURU) In 1935, Stein and Leventhal described 7 women with bilateral enlarged PCO, amenorrhea or irregular menses, infertility and masculinizing
More informationEndocrine and Reproductive Systems. Chapter 39: Biology II
Endocrine and Reproductive Systems Chapter 39: Biology II The Endocrine System Made up of glands that release their products into the bloodstream These products broadcast messages throughout the body Chemicals
More informationEstrogens vs Testosterone for cardiovascular health and longevity
Estrogens vs Testosterone for cardiovascular health and longevity Panagiota Pietri, MD, PhD, FESC Director of Hypertension Unit Athens Medical Center Athens, Greece Women vs Men Is there a difference in
More informationCancer in Women after Menopause
Cancer in Women after Menopause BELGIAN MENOPAUSE SOCIETY SEPTEMBER 19, 2009 A. Pintiaux ULg Gynaecological Uses of a New Class of Steroids : the Selective Progesterone Receptor Modulators BELGIAN MENOPAUSE
More informationObesity and Breast Cancer in a Multiethnic Population. Gertraud Maskarinec, MD, PhD University of Hawaii Cancer Center, Honolulu, HI
Obesity and Breast Cancer in a Multiethnic Population Gertraud Maskarinec, MD, PhD University of Hawaii Cancer Center, Honolulu, HI Background Breast cancer incidence remains lower in many Asian than Western
More informationMetabolic changes in menopausal transition
Metabolic changes in menopausal transition Terhi T. Piltonen M.D., Associate Professor Consultant, Clinical Researcher for the Finnish Medical Foundation Department of Obstetrics and Gynecology PEDEGO
More informationBreast Cancer Risk in Patients Using Hormonal Contraception
Breast Cancer Risk in Patients Using Hormonal Contraception Bradley L. Smith, Pharm.D. Smith.bradley1@mayo.edu Pharmacy Ground Rounds Mayo Clinic Rochester April 3 rd, 2018 2017 MFMER slide-1 Presentation
More informationBREAST PATHOLOGY. Fibrocystic Changes
BREAST PATHOLOGY Lesions of the breast are very common, and they present as palpable, sometimes painful, nodules or masses. Most of these lesions are benign. Breast cancer is the 2 nd most common cause
More information